Over the past few decades, advances in pharmacological, catheter-based, and surgical
reperfusion have improved outcomes for patients with acute myocardial infarctions …

Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute
myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded …

Longevity is increasing, and more adults are living to the stage of life when age-related
biological factors determine a higher likelihood of cardiovascular disease in a distinctive …

Background: Little is known about clinical characteristics, hospital course, and longitudinal
outcomes of patients with cardiogenic shock (CS) related to heart failure (HF-CS) compared …

Older patients are underrepresented in prospective studies and randomized clinical trials of
acute coronary syndromes (ACS). Over the last decade, a few specific trials have been …

Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

Objective To evaluate outcomes by sex in older adults with cardiogenic shock complicating
acute myocardial infarction (AMI-CS). Materials and Methods A retrospective cohort of older …

Background: There are substantial geographic disparities in the life expectancy (LE) across
the US with myocardial infarction (MI) contributing significantly to the differences between …

Abstract In the United States, the frequency of using percutaneous mechanical circulatory
support devices for acute myocardial infarction complicated by cardiogenic shock is …

Background The in-hospital mortality of patients with ST-segment elevation myocardial
infarction (STEMI) increases to more than 50% following a cardiogenic shock (CS) event …